IMA Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

IMA Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Buy	+541	New	+$93K	0.01%	417
2019 Q1	–	Sell	-10	Closed	-$1K	–	302
2018 Q4	$1K	Hold	10	–	–	﹤0.01%	312
2018 Q3	$1K	Sell	10 -12	-55%	-$1.41K	﹤0.01%	321
2018 Q2	$2K	Buy	+22	New	+$2.35K	﹤0.01%	396

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

IMA Advisory Services's IBB Position: Q2 2026 in Review

IMA Advisory Services opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 541 shares worth $103K. The stake represents 0.01% of the portfolio and ranks #417 among its holdings. This is a return to the name: IMA Advisory Services previously reported a position in IBB as recently as Q4 2018.

IMA Advisory Services first reported a position in IBB in Q2 2018 and has held it in 4 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

IMA Advisory Services held 541 shares of iShares Biotechnology ETF worth $103K as of Q2 2026.
iShares Biotechnology ETF was a new IMA Advisory Services position in Q2 2026.
iShares Biotechnology ETF made up 0.01% of IMA Advisory Services's portfolio in Q2 2026, its #417 holding.
IMA Advisory Services first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 4 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.